192 related articles for article (PubMed ID: 18069598)
41. Reduced atrial fibrillation incidence by angiotensin-converting enzyme inhibitors: a possible contributing mechanism.
El Muayed M
J Am Coll Cardiol; 2005 Apr; 45(7):1144; author reply 1144. PubMed ID: 15808777
[No Abstract] [Full Text] [Related]
42. Anti-inflammatory and antioxidant actions of statins may favorably affect atrial remodeling in atrial fibrillation.
Korantzopoulos P; Kountouris E; Kolettis T; Siogas K
Am J Cardiol; 2004 May; 93(9):1200. PubMed ID: 15110227
[No Abstract] [Full Text] [Related]
43. Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy.
Ogimoto A; Shigematsu Y; Higaki J; Miki T
Am Heart J; 2005 Mar; 149(3):566. PubMed ID: 15864221
[No Abstract] [Full Text] [Related]
44. Surgical treatment of atrial fibrillation.
El Oumeiri B; Casselman F; Geelen P; Wellens F; Degrieck I; Van Praet F; Cammu G; Vermeulen Y; Vanermen H
Minerva Cardioangiol; 2007 Jun; 55(3):369-78. PubMed ID: 17534255
[TBL] [Abstract][Full Text] [Related]
45. Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme.
Zhang W; Zhong M; Yang GR; Li JP; Guo C; Wang Z; Zhang Y
Cardiovasc Pathol; 2008; 17(6):399-409. PubMed ID: 18706834
[TBL] [Abstract][Full Text] [Related]
46. Pharmacotherapy of atrial fibrillation: an old option with new possibilities.
Janko S; Dorwarth U; Hoffmann E
Expert Opin Pharmacother; 2008 Apr; 9(6):913-25. PubMed ID: 18377335
[TBL] [Abstract][Full Text] [Related]
47. Are you missing your "must-use" medications?
Harv Heart Lett; 2003 Apr; 13(8):6-7. PubMed ID: 12711577
[No Abstract] [Full Text] [Related]
48. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
49. [Therapeutic aims for atrial fibrillation in patients with heart failure].
Lewalter T; Nitschmann S
Internist (Berl); 2009 Jan; 50(1):101-3. PubMed ID: 19137270
[No Abstract] [Full Text] [Related]
50. Atrial remodeling in persistent atrial fibrillation: the potential role of aldosterone.
Korantzopoulos P; Kolettis T; Kountouris E; Siogas K
Eur Heart J; 2004 Jun; 25(12):1086; author reply 1086-7. PubMed ID: 15191783
[No Abstract] [Full Text] [Related]
51. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
[TBL] [Abstract][Full Text] [Related]
52. Anti-inflammatory effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Potential benefits for the prevention of atrial fibrillation.
Liu T; Li G
Eur Heart J; 2006 Oct; 27(19):2370-1; author reply 2371. PubMed ID: 16966344
[No Abstract] [Full Text] [Related]
53. [Arterial hypertension and cardiac arrhythmias].
Vester EG
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
[TBL] [Abstract][Full Text] [Related]
54. Atrial fibrillation following cardiac surgery: clinical features and preventative strategies.
Kaireviciute D; Aidietis A; Lip GY
Eur Heart J; 2009 Feb; 30(4):410-25. PubMed ID: 19174427
[TBL] [Abstract][Full Text] [Related]
55. Cardioversion of atrial fibrillation for maintenance of sinus rhythm: a road to nowhere.
Wyse DG; Anter E; Callans DJ
Circulation; 2009 Oct; 120(14):1444-52. PubMed ID: 19805661
[No Abstract] [Full Text] [Related]
56. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
Casaclang-Verzosa G; Gersh BJ; Tsang TS
J Am Coll Cardiol; 2008 Jan; 51(1):1-11. PubMed ID: 18174029
[TBL] [Abstract][Full Text] [Related]
57. Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation.
Tsai CT; Lai LP; Hwang JJ; Chen WP; Chiang FT; Hsu KL; Tseng CD; Tseng YZ; Lin JL
J Hypertens; 2008 Mar; 26(3):570-82. PubMed ID: 18300870
[TBL] [Abstract][Full Text] [Related]
58. [Atrial fibrillation after coronary artery bypass grafting].
Simonenko VB; Borisov IA; Golikov AP; Dieva TV; Savichev DD
Klin Med (Mosk); 2009; 87(8):4-6. PubMed ID: 19827521
[TBL] [Abstract][Full Text] [Related]
59. Atrial fibrillation and congestive heart failure.
Bourke T; Boyle NG
Minerva Med; 2009 Apr; 100(2):137-43. PubMed ID: 19390499
[TBL] [Abstract][Full Text] [Related]
60. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
